Alpha 2.0
Login Register
» Authors » L Farnault

L Farnault

Explore the profile of L Farnault including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 85
Followers 0
Related Specialties
General Surgery
Pediatrics
Hematology
Top 10 Co-Authors
G Venton
J Colle
R Costello
R Fanciullino
P Suchon
C Mercier
Y Labiad
C Baier
R Arcani
V Ivanov
Published In
Bone Marrow Transplant
Arch Pediatr
Med Mal Infect
Transfus Apher Sci
Ann Hematol
Affiliations
Soon will be listed here.
Recent Articles
1.
Azacitidine, a therapeutic option in Lewis and Sumner syndrome associated with VEXAS syndrome
Escoda T, Farnault L, Gallard J, Marceau-Renaut A, Attarian S, Delmont E
Rev Neurol (Paris) . 2022 Nov; 178(10):1109-1111. PMID: 36369067
No abstract available.
2.
High incidence of CDA deficiency in patients with hematological malignancies: perspectives and therapeutic implications
Donnette M, Ciccolini J, Pissier C, Costello R, Duffaud F, Salas S, et al.
Ann Oncol . 2021 Feb; 32(5):684-686. PMID: 33529741
No abstract available.
3.
Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen
Farnault L, Venton G, Pourroy B, Jourde-Chiche N, Ivanov V, Arcani R, et al.
Bone Marrow Transplant . 2019 Feb; 54(7):1173-1175. PMID: 30718799
No abstract available.
4.
Hematopoietic reconstitution after autologous hematopoietic stem cell transplantation: do CD45 (+) CD34 (+) CD38 (-) progenitors really matter in real life?
Venton G, Suchon P, Colle J, Baier C, Sanderson F, Poullin P, et al.
Transfus Apher Sci . 2018 May; 57(3):406-408. PMID: 29709543
No abstract available.
5.
Aldehyde dehydrogenases inhibition eradicates leukemia stem cells while sparing normal progenitors
Venton G, Perez-Alea M, Baier C, Fournet G, Quash G, Labiad Y, et al.
Blood Cancer J . 2016 Sep; 6(9):e469. PMID: 27611922
The vast majority of patients with acute myeloid leukemia (AML) achieve complete remission (CR) after standard induction chemotherapy. However, the majority subsequently relapse and die of the disease. A leukemia...
6.
Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis
Venton G, Labiad Y, Colle J, Fino A, Afridi S, Torres M, et al.
Immunol Res . 2016 Aug; 64(5-6):1225-1236. PMID: 27481509
Chemotherapies allow complete remission in more than 50 % of patients with acute myeloid leukemia (AML), however, with frequent relapse. This suggests that residual leukemic cells may escape to chemotherapy...
7.
Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia
Venton G, Adam H, Colle J, Labiad Y, Mercier C, Ivanov V, et al.
Med Mal Infect . 2016 Apr; 46(4):226-9. PMID: 27126350
Objective: To study the efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing induction chemotherapy for acute myeloid leukemia. Patients And Methods: A prospective observational...
8.
Full but impaired activation of innate immunity effectors and virus-specific T cells during CMV and EBV disease following cord blood transplantation
Farnault L, Gertner-Dardenne J, Gondois-Rey F, Michel G, Chambost H, Hirsch I, et al.
Bone Marrow Transplant . 2015 Jan; 50(3):459-62. PMID: 25599160
No abstract available.
9.
Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation
Farnault L, Gertner-Dardenne J, Gondois-Rey F, Michel G, Chambost H, Hirsch I, et al.
Bone Marrow Transplant . 2013 Jul; 48(11):1478-9. PMID: 23832093
No abstract available.
10.
Recurrent superior vena cava syndrome caused by IgD multiple myeloma
Farnault L, Chebrek S, Souteyrand P, Sebahoun G, Costello R
Ann Hematol . 2012 May; 91(12):1977-8. PMID: 22638757
No abstract available.